Teva Pharmaceutical Inds LTD Sponsored Adr (TEVA) Holder Clal Insurance Enterprises Holdings LTD Has Boosted Its Position by $1.50 Million; General American Investors Company Has Decreased Its Nelnet (NNI) Stake by $1.75 Million as Share Price Declined

January 19, 2018 - By Clifton Ray

General American Investors Company Inc decreased its stake in Nelnet Inc. (NNI) by 8.24% based on its latest 2017Q3 regulatory filing with the SEC. General American Investors Company Inc sold 35,000 shares as the company’s stock declined 21.49% while stock markets rallied. The institutional investor held 390,000 shares of the finance company at the end of 2017Q3, valued at $19.70M, down from 425,000 at the end of the previous reported quarter. General American Investors Company Inc who had been investing in Nelnet Inc. for a number of months, seems to be less bullish one the $2.15 billion market cap company. The stock increased 0.37% or $0.19 during the last trading session, reaching $52.56. About 23,803 shares traded. Nelnet, Inc. (NYSE:NNI) has risen 13.42% since January 19, 2017 and is uptrending. It has underperformed by 3.28% the S&P500.

Clal Insurance Enterprises Holdings Ltd increased its stake in Teva Pharmaceutical Inds Ltd Sponsored Adr (TEVA) by 2.95% based on its latest 2017Q3 regulatory filing with the SEC. Clal Insurance Enterprises Holdings Ltd bought 88,151 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 3.08M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $54.19 million, up from 2.99M at the end of the previous reported quarter. Clal Insurance Enterprises Holdings Ltd who had been investing in Teva Pharmaceutical Inds Ltd Sponsored Adr for a number of months, seems to be bullish on the $20.76B market cap company. The stock decreased 1.33% or $0.275 during the last trading session, reaching $20.435. About 15.63M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 19, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

General American Investors Company Inc, which manages about $1.05B US Long portfolio, upped its stake in Johnson Controls International by 45,000 shares to 315,000 shares, valued at $12.69 million in 2017Q3, according to the filing. It also increased its holding in General Electric Company (NYSE:GE) by 50,000 shares in the quarter, for a total of 870,000 shares, and has risen its stake in Now Inc. (NYSE:DNOW).

Investors sentiment decreased to 0.86 in Q3 2017. Its down 0.01, from 0.87 in 2017Q2. It dived, as 10 investors sold NNI shares while 41 reduced holdings. 11 funds opened positions while 33 raised stakes. 15.98 million shares or 5.39% less from 16.90 million shares in 2017Q2 were reported. Royal Financial Bank Of Canada holds 0% of its portfolio in Nelnet, Inc. (NYSE:NNI) for 3,639 shares. Tegean Cap Management Limited Liability Corporation holds 0.92% or 34,300 shares. 410,612 are held by State Street Corporation. Spark Mngmt Ltd reported 22,300 shares or 0.06% of all its holdings. Parametric Port Assoc Ltd Liability stated it has 81,453 shares or 0% of all its holdings. 40,525 were reported by Fmr Limited Com. Barclays Public Limited Co holds 21,663 shares or 0% of its portfolio. Boston Ptnrs stated it has 1.07 million shares or 0.07% of all its holdings. Buckingham Asset Mngmt Limited Company holds 0.16% of its portfolio in Nelnet, Inc. (NYSE:NNI) for 13,365 shares. 179 are owned by Envestnet Asset Management. Susquehanna Intl Group Inc Llp holds 0% or 19,062 shares. Citadel Advsrs Ltd Co has invested 0% in Nelnet, Inc. (NYSE:NNI). Manufacturers Life The stated it has 15,684 shares or 0% of all its holdings. New York State Common Retirement Fund reported 21,900 shares stake. Great West Life Assurance Can owns 1,783 shares or 0% of their US portfolio.

Among 2 analysts covering Nelnet (NYSE:NNI), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Nelnet had 9 analyst reports since August 7, 2015 according to SRatingsIntel. Compass Point maintained the stock with “Buy” rating in Monday, November 9 report. The firm has “Neutral” rating given on Monday, November 14 by Credit Suisse. Credit Suisse maintained Nelnet, Inc. (NYSE:NNI) rating on Friday, August 7. Credit Suisse has “Outperform” rating and $56 target. Credit Suisse maintained Nelnet, Inc. (NYSE:NNI) on Friday, October 20 with “Neutral” rating. The stock has “Neutral” rating by Compass Point on Wednesday, August 9. The company was upgraded on Thursday, October 19 by Compass Point. On Friday, August 7 the stock rating was maintained by Compass Point with “Buy”.

Since August 18, 2017, it had 0 insider purchases, and 5 sales for $407,520 activity. MUHLEISEN ANGIE sold $115,080 worth of stock or 2,000 shares.

Clal Insurance Enterprises Holdings Ltd, which manages about $4.14B US Long portfolio, decreased its stake in Proshares Tr Shrt 20Plus Yr Tre (TBF) by 344,032 shares to 11,189 shares, valued at $251,000 in 2017Q3, according to the filing. It also reduced its holding in Ishares Tr Russell 2000 Etf (IWM) by 1.23M shares in the quarter, leaving it with 694,088 shares, and cut its stake in Mylan N V Shs Euro (NASDAQ:MYL).

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 7 Sell and 18 Hold. Therefore 24% are positive. Teva Pharma had 129 analyst reports since July 21, 2015 according to SRatingsIntel. Goldman Sachs downgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Friday, July 15 to “Neutral” rating. The stock has “Buy” rating by BTIG Research on Monday, September 11. The stock has “Underperform” rating by Credit Suisse on Thursday, August 24. The firm has “Neutral” rating by Nomura given on Tuesday, September 29. Mizuho maintained it with “Buy” rating and $64.0 target in Thursday, August 25 report. The stock has “Sell” rating by Leerink Swann on Tuesday, January 2. Oppenheimer reinitiated the stock with “Outperform” rating in Wednesday, December 7 report. Cantor Fitzgerald initiated the stock with “Neutral” rating in Friday, June 16 report. The firm earned “Market Perform” rating on Monday, January 9 by Wells Fargo. As per Wednesday, October 4, the company rating was maintained by Cowen & Co.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: